Login / Signup

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive-A randomized controlled trial.

Marcus-Hillert Schultze-MosgauBarbara SchüttCorinna DraegerManuela CasjensStephanie LoewenTorsten ZimmermannBeate Rohde
Published in: British journal of clinical pharmacology (2020)
The SPRM VPR interfered with the pharmacodynamic effects of the COC. Therefore, full contraceptive effectiveness cannot be assumed without final judgement by a Pearl index study. Women on SPRMs should be advised to use nonhormonal contraception methods.
Keyphrases
  • randomized controlled trial
  • systematic review
  • polycystic ovary syndrome
  • adipose tissue
  • cervical cancer screening